Empire Life Investments’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-6,730
| Closed | -$228K | – | 97 |
|
|
2022
Q4 | $228K | Sell |
6,730
-82
| -1% | -$2.78K | 0.02% | 92 |
|
|
2022
Q3 | $327K | Buy |
6,812
+238
| +4% | +$11.4K | 0.02% | 90 |
|
|
2022
Q2 | $375K | Buy |
6,574
+125
| +2% | +$7.13K | 0.03% | 92 |
|
|
2022
Q1 | $521K | Buy |
6,449
+33
| +0.5% | +$2.67K | 0.03% | 90 |
|
|
2021
Q4 | $1.3M | Buy |
6,416
+15
| +0.2% | +$3.04K | 0.08% | 84 |
|
|
2021
Q3 | $1.73M | Buy |
6,401
+23
| +0.4% | +$6.2K | 0.11% | 76 |
|
|
2021
Q2 | $1.64M | Buy |
6,378
+100
| +2% | +$25.7K | 0.11% | 75 |
|
|
2021
Q1 | $1.88M | Sell |
6,278
-133
| -2% | -$39.9K | 0.13% | 78 |
|
|
2020
Q4 | $1.64M | Sell |
6,411
-33
| -0.5% | -$8.42K | 0.12% | 83 |
|
|
2020
Q3 | $1.6M | Buy |
6,444
+20
| +0.3% | +$4.98K | 0.13% | 73 |
|
|
2020
Q2 | $2.23M | Sell |
6,424
-426
| -6% | -$148K | 0.2% | 61 |
|
|
2020
Q1 | $1.83M | Buy |
6,850
+106
| +2% | +$28.4K | 0.17% | 73 |
|
|
2019
Q4 | $2.18M | Buy |
6,744
+34
| +0.5% | +$11K | 0.17% | 67 |
|
|
2019
Q3 | $1.83M | Buy |
6,710
+391
| +6% | +$107K | 0.15% | 73 |
|
|
2019
Q2 | $3.37M | Buy |
6,319
+90
| +1% | +$48K | 0.27% | 71 |
|
|
2019
Q1 | $3.14M | Buy |
6,229
+2,492
| +67% | +$1.26M | 0.26% | 68 |
|
|
2018
Q4 | $1.84M | Buy |
3,737
+52
| +1% | +$25.6K | 0.17% | 73 |
|
|
2018
Q3 | $3.37M | Sell |
3,685
-25
| -0.7% | -$22.9K | 0.26% | 77 |
|
|
2018
Q2 | $2.72M | Buy |
+3,710
| New | +$2.72M | 0.2% | 81 |
|